NHS

News

AZ CEO Soriot urges caution on COVID booster doses

The UK should think twice before backing widespread use of COVID-19 booster vaccinations, as to do so could place unnecessary burden on the NHS over the winter, according to AstraZeneca chi

News

NICE changes its mind on J&J's Erleada in prostate cancer

NICE has reversed its position on Johnson & Johnson's oral prostate cancer therapy Erleada in patients with hormone-relapsed or hormone sensitive tumours, backing NHS use of the drug.

News

Blurred figures of people with medical uniforms in hospital corridor

UK pledges £5.4bn to NHS to ease COVID-19 treatment backlog

NHS England will get an extra £5.4 billion ($7.5 billion) in funding over the next six months to respond to COVID-19 and address a backlog in care caused by the pandemic, according to the U

News

Study backs benefit of insomnia DTx Sleepio on mental health

A study has shown that people with anxiety or depression who used a digital therapeutic (DTx) for insomnia alongside psychological therapy had better improvement in their mental health than

News

NICE backs Cosentyx' use in thousands of children with psori...

NICE has recommended broadening NHS use of Novartis' IL-17 inhibitor Cosentyx to include children aged six to 17 with severe plaque psoriasis.

News

NICE backs NHS use of Novartis' cholesterol drug Leqvio

Novartis' cholesterol-lowering drug Leqvio will be made available on the NHS in England and Wales, and could help to prevent up to 30,000 deaths, according to NICE.

AZ CEO Soriot urges caution on COVID booster doses

NICE changes its mind on J&J's Erleada in prostate cancer

UK pledges £5.4bn to NHS to ease COVID-19 treatment backlog

Study backs benefit of insomnia DTx Sleepio on mental health

NICE backs Cosentyx' use in thousands of children with psori...

NICE backs NHS use of Novartis' cholesterol drug Leqvio

GBL joins CVC in €10.7bn takeover bid for Recordati

Discover a new era of healthcare panel engagement: Grounded ...

NHS

Editor's Picks